Flavonoid modulation of GABA A receptors

British Journal of Pharmacology

Volumn 163, Issue 2, 2011, Pages 234-245

  Hanrahan, Jane R ^a   Chebib, Mary ^a   Johnston, Graham A R ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

allosteric modulation; flavonoids; GABA A receptors; ionotropic

Indexed keywords

3',7 DIHYDROXYISOFLAVAN; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4' HYDROXY 7 METHOXYISOFLAVONE; 6 BROMO 3' NITROFLAVONE; 6 BROMOFLAVONE; 6 CHLORO 3' NITROFLAVONE; 6 HYDROXYFLAVONE; 6,2' DIHYDROXYFLAVONE; 6,3' DINITROFLAVONE; AMENTOFLAVONE; ANTHOCYANIN; APIGENIN; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; DIHYDROFLAVONOL; EPIGALLOCATECHIN GALLATE; EQUOL; FLAVAN 3 OL; FLAVANDIOL; FLAVANONE; FLAVONE; FLAVONOID; FLAVONOL; FLUMAZENIL; FLUNITRAZEPAM; HISPIDULIN; ISOFLAVONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WOGONIN;

BINDING SITE; COGNITION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; IC 50; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

ANIMALS; BINDING SITES; FLAVONOIDS; FLUMAZENIL; GABA MODULATORS; HUMANS; RECEPTORS, GABA-A;

EID: 79954555973     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01228.x     Document Type: Review

References (98)

1. Adachi N, Tomonaga S, Tachibana T, Denbow DM, Furuse M, (2006). (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531: 171-175. (Pubitemid 43202231)
2. Akabas MH, (2004). GABAA receptor structure-function studies: a reexamination in light of new acetylcholine receptor structures. Int Rev Neurobiol 62: 1-43. (Pubitemid 39752440)
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1-S254.
4. Andres A, Donovan SM, Kuhlenschmidt MS, (2009). Soy isoflavones and virus infections. J Nutrit Biochem 20: 563-569.
5. Atack JR, (2005). The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Expert Opin Investig Drugs 14: 601-618. (Pubitemid 40790282)
6. Atack JR, (2008). GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer. CNS Neurosci Ther 14: 25-35.
7. Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M, (2000). Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. J Chem Inf Model 59: 1387-1394. (Pubitemid 30177355)
8. Baureithel KH, Buter KB, Engesser A, Burkard W, Schaffner W, (1997). Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharm Acta Helv 72: 153-157. (Pubitemid 27246713)
9. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ, (1997). The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci USA 94: 11031-11036.
10. Bohm BA, (1998). Introduction to Flavonoids, 1st edn. Taylor & Francis: Amsterdam.
11. Bond AJ, Haily DM, Lader MH, (1977). Plasma concentrations of benzodiazepines. Br J Clin Pharmacol 4: 51-56. (Pubitemid 8021540)
12. Campbell EL, Chebib M, Johnston GAR, (2004). The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA receptors. Biochem Pharmacol 68: 1631-1638. (Pubitemid 39286467)
13. Carter C, Kozuska J, Dunn S, (2010). Insights into the structure and pharmacology of GABAA receptors. Future Med Chem 2: 859-875.
14. Cazarolli LH, Zanatta L, Alberton EH, Figueiredo MSRB, Folador P, Damazio RG, et al,. (2008). Flavonoids: cellular and molecular mechanism of action in glucose homeostasis. Mini Rev Med Chem 8: 1032-1038.
15. Chebib M, Johnston GA, (2000). GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J Med Chem 43: 1427-1447. (Pubitemid 30238425)
16. Clarke D, Wiseman H, (2008). Phytoestrogens. In:, Gilbert J, Senyuva HZ, (eds). Bioactive Compounds in Food. John Wiley & Sons: Oxford, pp. 173-198.
17. Clayton T, Chen JL, Ernst M, Richter L, Cromer BA, Morton CJ, et al,. (2007). An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models. Curr Med Chem 14: 2755-2775. (Pubitemid 350130919)
18. Cushnie TPT, Lamb AJ, (2005). Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26: 343-356. (Pubitemid 41483464)
19. Dekermendjian K, Kahnberg P, Witt M-R, Sterner O, Nielsen M, Liljefors T, (1999). Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABAA receptor complex. J Med Chem 42: 4343-4350. (Pubitemid 29504138)
20. Drafts BC, Fisher JL, (2006). Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther 318: 1094-1101. (Pubitemid 44268315)
21. Drexler B, Jurd R, Rudolph U, Antkowiak B, (2009). Distinct actions of etomidate and propofol at beta3-containing gamma-aminobutyric acid type A receptors. Neuropharmacology 57: 446-455.
22. Fernandez SP, Wasowski C, Paladini AC, Marder M, (2005). Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur J Pharmacol 512: 189-198. (Pubitemid 40544353)
23. Fernandez SP, Mewett KN, Hanrahan JR, Chebib M, Johnston GAR, (2008). Flavan-3-ol derivatives are positive modulators of GABAA receptors with higher efficacy for the ?2 subtype and anxiolytic action in mice. Neuropharmacology 55: 900-907.
24. Franks NP, (2008). General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9: 370-386. (Pubitemid 351556044)
25. García-Lafuente A, Guillamõn E, Villares A, Rostagno MA, Martínez JA, (2009). Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res 58: 537-552.
26. Goutman JD, Waxemberg MD, Donate-Oliver F, Pomata PE, Calvo DJ, (2003). Flavonoid modulation of ionic currents mediated by GABAA and GABAC receptors. Eur J Pharmacol 461: 79-87. (Pubitemid 36174025)
27. Granger RE, Campbell EL, Johnston GAR, (2005). (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors. Biochem Pharmacol 69: 1101-1111. (Pubitemid 40349022)
28. Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ, (1999). Pharmacological studies on synthetic flavonoids: comparison with diazepam. Neuropharmacology 38: 965-977. (Pubitemid 29240613)
29. Gutmann H, Bruggisser R, Schaffner W, Bogman K, Botomino A, Drewe J, (2002). Transport of amentoflavone across the blood-brain barrier in vitro. Planta Med 68: 804-807. (Pubitemid 35177625)
30. Haberlein H, Tschiersch KP, Schafer HL, (1994). Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. Pharmazie 49: 912-922. (Pubitemid 24381214)
31. Hadingham KL, Wingrove PB, Wafford KA, Bain C, Kemp JA, Palmer KJ, et al,. (1993). The role of the beta subunit in determining the pharmacology of GABAA receptors. Mol Pharmacol 44: 1211-1218. (Pubitemid 24008605)
32. Hall BJ, Hanrahan JR, Johnston GAR, Hambley TW, Hibbs DE, (2001). 6-Methylflavone. Acta Crystallogr Sect E Struct Rep Online 57: o592-o593.
33. Hall BJ, Chebib M, Hanrahan JR, Johnston GAR, (2004). Flumazenil-independent positive modulation of γ-aminobutyric acid action by 6-methylflavone at human recombinant α1β2γ2L and α1β2 GABAA receptors. Eur J Pharmacol 491: 1-8. (Pubitemid 38501769)
34. Hall BJ, Chebib M, Hanrahan JR, Johnston GAR, (2005). 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant α2β2γ2L than at α1β2γ2L and α1β2 GABA(A) receptors expressed in Xenopus oocytes. Eur J Pharmacol 512: 97-104. (Pubitemid 40552793)
35. Hanrahan JR, Chebib M, Davucheron NLM, Hall BJ, Johnston GAR, (2003). Semisynthetic preparation of amentoflavone: a negative modulator at GABAA receptors. Bioorg Med Chem Lett 13: 2281-2284. (Pubitemid 36724966)
36. Hansen RS, Paulsen I, Davies M, (2005). Determinants of amentoflavone interaction at the GABAA receptor. Eur J Pharmacol 519: 199-207. (Pubitemid 41278538)
37. Hosie AM, Wilkins ME, da Silva HM, Smart TG, (2006). Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444: 486-489. (Pubitemid 44809065)
38. Hosie AM, Wilkins ME, Smart TG, (2007). Neurosteroid binding sites on GABA(A) receptors. Pharmacol Ther 116: 7-19. (Pubitemid 47398919)
39. A receptors. Neuropharmacology 56: 149-154.
40. Huang X, Liu T, Gu J, Luo X, Ji R, Cao Y, et al,. (2001). 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. J Med Chem 44: 1883-1891. (Pubitemid 32884513)
41. Huen MSY, Hui K-M, Leung JWC, Sigel E, Baur R, Wong JT-F, et al,. (2003a). Naturally occurring 2′-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. Biochem Pharmacol 66: 2397-2407. (Pubitemid 37456746)
42. Huen MSY, Leung JWC, Ng W, Lui WS, Chan MNS, Wong JT-F, et al,. (2003b). 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem Pharmacol 66: 125-132. (Pubitemid 36724906)
43. Hui KM, Huen Michael SY, Wang Hong Y, Zheng H, Sigel E, Baur R, et al,. (2002). Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol 64: 1415-1424. (Pubitemid 35248258)
44. Jager AK, Almquist JP, Vangsoe SAK, Stafford GI, Adsersen A, van Staden J, (2007). Compounds from Mentha aquatica with affinity to the GABA-benzodiazepine receptor. S Afr J Bot 73: 518-521. (Pubitemid 47588479)
45. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, et al,. (2001). Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 21: RC136.
46. Johnston GAR, (2005). GABA(A) receptor channel pharmacology. Curr Pharm Des 11: 1867-1885.
47. Kahnberg P, Lager E, Rosenberg C, Schougaard J, Camet L, Sterner O, et al,. (2002). Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABAA receptor. J Med Chem 45: 4188-4201. (Pubitemid 35025568)
48. Kale A, Gawande S, Kotwal S, (2008). Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother Res 22: 567-577. (Pubitemid 351716542)
49. Karim N, Gavande N, Johnston GA, Hanrahan JR, (2010). Chebib M 2′-Methoxy-6-methylflavone: a novel allosteric activator of α4β1/3δ GABAA receptors. In: Neuroscience Meeting Planner (ed.). Program No 3385/E26 2010. Society for Neuroscience: San Diego, CA. Online.
50. Kavvadias D, Sand P, Youdim KA, Qaiser MZ, Rice-Evans C, Baur R, et al,. (2004). The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 142: 811-820. (Pubitemid 38998095)
51. Krasowski MD, O'Shea SM, Rick CE, Whiting PJ, Hadingham KL, Czajkowski C, et al,. (1997). Alpha subunit isoform influences GABA(A) receptor modulation by propofol. Neuropharmacology 36: 941-949. (Pubitemid 27300124)
52. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL, (1998). Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 53: 530-538. (Pubitemid 28162877)
53. Li GD, Chiara DC, Cohen JB, Olsen RW, (2010). Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors. J Biol Chem 285: 8615-8620.
54. Luk KC, Stern L, Weigele M, O'Brien RA, Spirst N, (1983). Isolation and identification of 'diazepam-like' compounds in bovine brain. J Nat Prod 46: 852-861. (Pubitemid 14183476)
55. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L, (2004). Polyphenols: food sources and bioavailability. Am J Clin Nutr 79: 727.
56. Marder M, Paladini AC, (2002). GABAA-receptor ligands of flavonoid structure. Curr Top Med Chem 2: 853-867.
57. Marder M, Viola H, Bacigaluppo JA, Colombo MI, Wasowski C, Wolfman C, et al,. (1988). Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem Biophys Res Commun 249: 481-485.
58. Marder M, Viola H, Wasowski C, Wolfman C, Waterman PG, Cassels BK, et al,. (1996). 6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids. Biochem Biophys Res Commun 223: 384-389. (Pubitemid 26245577)
59. Marder M, Estiu G, Blanch LB, Viola H, Wasowski C, Medina JH, et al,. (2001). Molecular modeling and QSAR analysis of the interaction of flavone derivatives with the benzodiazepine binding site of the GABAA receptor complex. Bioorg Med Chem 9: 323-335. (Pubitemid 32244031)
60. Medina JH, Viola H, Wolfman C, Marder M, Wasowski C, Calvo D, et al,. (1997). Flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 22: 419-425. (Pubitemid 27184706)
61. Mesce KA, (2002). Metamodulation of the biogenic amines: second order modulation by setroid hormones and amine cocktails. Brain Behav Evol 60: 339-349. (Pubitemid 36160299)
62. Mewett KN, Fernandez SP, Pasricha AK, Pong A, Devenish SO, Hibbs DE, et al,. (2009). Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptors. Bioorg Med Chem 17: 7156-7173.
63. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, et al,. (1997). Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389: 385-389. (Pubitemid 27415220)
64. Nielsen M, Froekjaer S, Braestrup C, (1988). High affinity of the naturally-occurring biflavonoid, amentoflavone, to brain benzodiazepine receptors in vitro. Biochem Pharmacol 37: 3285-3287.
65. Ognibene E, Bovicelli P, Adriani W, Saso L, Laviola G, (2008). Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds. Prog Neuropsychopharmacol Biol Psychiatry 32: 128-134.
66. Olsen RW, Sieghart W, (2009). GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56: 141-148.
67. Paladini AC, Marder M, Viola H, Wolfman C, Wasowski C, Medina JH, (1999). Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 51: 519-526. (Pubitemid 29319776)
68. Park HG, Yoon SY, Choi JY, Lee GS, Choi JH, Shin CY, et al,. (2007). Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur J Pharmacol 574: 112-119. (Pubitemid 47575523)
69. Puia G, Vicini S, Seeburg PH, Costa E, (1991). Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol 39: 691-696.
70. Rathee P, Chaudhary H, Rathee S, Rathee D, Kumar V, Kohli K, (2009). Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets 8: 229-235.
71. Ren L, Wanga F, Xua Z, Chana WM, Zhaoa C, Xue H, (2010). GABAA receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone. Biochem Pharmacol 79: 1337-1344.
72. Ribeiro JA, Sebastiao AM, (2010). Modulation and metamodulation of synapses by adenosine. Acta Physiologica 199: 161-169.
73. Rudolph U, Antkowiak B, (2004). Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5: 709-720. (Pubitemid 39150142)
74. Rudolph U, Mohler H, (2004). Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44: 475-498. (Pubitemid 38263850)
75. Rudolph U, Mohler H, (2006). GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 6: 18-23. (Pubitemid 43103815)
76. Salgueiro JB, Ardenghi P, Dias M, Ferreira MB, Izquierdo I, Medina JH, (1997). Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav 58: 887-891. (Pubitemid 28108193)
77. Schofield CM, Harrison NL, (2005). Transmembrane residues define the action of isoflurane at the GABAA receptor alpha-3 subunit. Brain Res 1032: 30-35. (Pubitemid 40170305)
78. Spencer JPE, (2009). Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr 4: 243-250.
79. Spencer JPE, Vauzour D, Rendeiro C, (2009). Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys 492: 1-9.
80. Svenningsen AB, Madsen KD, Liljefors T, Stafford GI, van Staden J, Jaeger AK, (2006). Biflavones from Rhus species with affinity for the GABAA/benzodiazepine receptor. J Ethnopharmacol 103: 276-280. (Pubitemid 41796928)
81. Thompson SA, Whiting PJ, Wafford KA, (1996). Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br J Pharmacol 117: 521-527.
82. Vignes M, Maurice T, Lanté F, Nedjar M, Thethi K, Guiramand J, et al,. (2006). Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 1110: 102-115. (Pubitemid 44344606)
83. Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silvera R, Medina AE, et al,. (1995). Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med 61: 213-216.
84. Viola H, Marder M, Wolfman C, Wasowski C, Medina JH, Paladini AC, (1998). Central nervous system effects of natural and synthetic flavonoids. Anales de la Asociacion Quimica Argentina 86: 229-236. (Pubitemid 128758350)
85. Viola H, Wolfman C, Marder M, Goutman JD, Bianchin M, Wasowski C, et al,. (2000). 6-Chloro-3′-nitroflavone is a potent ligand for the benzodiazepine binding site of the GABA(A) receptor devoid of intrinsic activity. Pharmacol Biochem Behav 65: 313-320. (Pubitemid 30100278)
86. Wafford KA, Bain CJ, Whiting PJ, Kemp JA, (1993). Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors. Mol Pharmacol 44: 437-442. (Pubitemid 23252252)
87. Walters RJ, Hadley SH, Morris KDW, Amin J, (2000). Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat Neurosi 3: 1274-1281.
88. Wang H, Hui K-M, Chen Y, Xu S, Wong JT-F, Xue H, (2002). Structure-activity relationships of flavonoids, isolated from Scutellaria baicalensis, binding to benzodiazepine site of GABAA receptor complex. Planta Med 68: 1059-1062. (Pubitemid 36140307)
89. Wang F, Xu Z, Yuen CT, Chow CY, Lui YL, Tsang SY, et al,. (2007). 6,2′-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site. Neuropharmacology 53: 574-582. (Pubitemid 47284190)
90. Whiting PJ, (2003). GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 8: 445-450. (Pubitemid 36686731)
91. Whiting PJ, (2006). GABA-A receptors: a viable target for novel anxiolytics? Curr Opin Pharmacol 6: 24-29. (Pubitemid 43103816)
92. Wieland HA, Luddens H, Seeburg PH, (1992). A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J Biol Chem 267: 1426-1429.
93. Williams RJ, Spencer JP, Rice-Evancs C, (2004). Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849. (Pubitemid 38352901)
94. Wolfman C, Viola H, Marder M, Ardenghi P, Wasowski C, Schroder N, et al,. (1998). Pharmacological characterization of 6-bromo-3′-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Pharmacol Biochem Behav 61: 239-246. (Pubitemid 28498206)
95. Yao N, Song A, Wang X, Dixon S, Lam KS, (2007). Synthesis of flavonoid analgues as scaffolds for natural product-based combinatorial libraries. J Comb Chem 9: 668-676.
96. Youdim KA, Shukitt-Hale B, Joseph JA, (2004). Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37: 1683-1693. (Pubitemid 39441053)
97. Zanoli P, Avallone R, Baraldi M, (2000). Behavioral characterization of the flavonoids apigenin and chrysin. Fitoterapia 71: S117-S123. (Pubitemid 30621704)
98. Zhang W, Koehler KF, Zhang P, Cook JM, (1995). Development of a comprehensive pharmacophore model for the benzodiazepine receptor. Drug Des Discov 12: 193-248.